close

Clinical Trials

1 2 3 4 219
Number of results: 4372

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2018-10-12 evobrutinib - M2951 relapsing multiple sclerosis (RMS) 2 Merck KGaA (Germany) Autoimmune diseases - Neurodegenerative diseases
2018-10-12 Opdivo® (nivolumab) relapsed small cell lung cancer 3 BMS (USA - NY) Cancer - Oncology
2018-10-12 CMB305 and atezolizumab soft tissue sarcoma, locally advanced, relapsed, or metastatic NY-ESO-1+ synovial sarcoma or myxoid/round-cell liposarcoma. 2 Immune Design (USA - MA) Cancer - Oncology
2018-10-12 CMB305 (LV305 and G305) - dendritic-cell targeting, lentiviral vector encoding the NY-ESO-1 gene05 synovial sarcoma 3 Immune Design (USA - MA) Cancer - Oncology
2018-10-11 lifileucel - LN-144 metastatic melanoma 2 Lion Biotechnologies (USA - CA), now Iovance Biotherapeutics (USA - CA) Cancer - Oncology
2018-10-06 LOXO-292 RET-fusion non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC) and other tumors with increased RET activity 1-2 Loxo Oncology (USA - CT) Cancer - Oncology
2018-10-06 Translarna™ (ataluren) Duchenne muscular dystrophy observational PTC Therapeutics (USA - NJ) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-06 Spinraza® (nusinersen) spinal muscular atrophy (SMA) 2 Biogen (USA - MA) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-05 AT132 X-Linked Myotubular Myopathy (XLMTM) 1-2 Audentes Therapeutics (USA - CA) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-05 Orbactiv™ (oritavancin) infections due to presumed or confirmed gram-positive bacteria observational Melinta Therapeutics (USA - CT) Infectious diseases
2018-10-04 birinapant and pembrozilumab treatment-resistant solid tumours 1-2 Medivir (Sweden) Cancer - Oncology
2018-10-03 risdiplam - RG7916/RO7034067 type 1spinal muscular atrophy (SMA) 2 PTC Therapeutics (USA - NJ) Roche (Switzerland) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-03 AAVrh74.MHCK7.micro-Dystrophin Duchenne muscular dystrophy (DMD) 1-2 Sarepta Therapeutics (USA - MA) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-10-03 Biktarvy® (BIC/FTC/TAF - bictegravir (50 mg) and emtricitabine/tenofovir alafenamide (200/25 mg) (FTC/TAF) HIV-1 infection in adults 3 Gilead Sciences (USA - CA) Infectious diseases
2018-10-03 ALN-AAT02 AAT deficiency-associated liver disease (alpha-1 liver disease) 1-2 Alnylam Therapeutics (USA - MA) Rare diseases - Genetic diseases - Hepatic diseases - Liver diseases
2018-10-02 Kineret® (anakinra) acute gout 2 Swedish Orphan Biovitrum - SOBI (Sweden) Inflammatory diseases
2018-10-01 MIV-818 advanced liver cancer including hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma and liver metastases from solid tumors 1-2 Medivir (Sweden) Cancer - Oncology
2018-09-29 IPH4102 cutaneous T-cell lymphoma (CTCL) and especially their aggressive forms: Sezary Syndrome and Transformed Mycosis Fungoides 1 Innate Pharma (France) Cancer - Oncology - Rare diseases
2018-09-28 ATOR-1017 preclinical Alligator Bioscience (Sweden) Cancer - Oncology
2018-09-27 givosiran (ALN-AS1) acute hepatic porphyria 3 Alnylam Therapeutics (USA - MA) Rare diseases - Metabolic diseases